,Date,Study,Study Link,Journal,Study Type,Material,Method,Days After Onset/Admission (+) Covid-19 Presence (maximum unless otherwise stated),Property 2,Conclusion,Measure of Evidence,Added on
0,2020-03-26,Viral Kinetics and Antibody Responses in Patients with COVID-19,https://doi.org/10.1101/2020.03.24.20042382,medRxiv,Prospective Cohort,Blood,qRT-PCR confirmed,-,-,Only 5.7% plasma samples positive; blood is not a major shedding route,patients: 67,04/08/2020
1,2020-03-11,Comparisons of nucleic acid conversion time of SARS-CoV-2 of different samples in ICU and non-ICU patients,https://www.journalofinfection.com/article/S0163-4453(20)30139-0/fulltext,Journal of Infection,Retrospective Analysis,Blood,RT-PCR confirmed,median: 14.63±5.878,-,Positive rate in blood = 87.5% (7/8) in ICU and 66.7% (16/24) in non-ICU,"patients: 32, severity: ICU",04/13/2020
2,2020-03-11,Comparisons of nucleic acid conversion time of SARS-CoV-2 of different samples in ICU and non-ICU patients,https://www.journalofinfection.com/article/S0163-4453(20)30139-0/fulltext,Journal of Infection,Retrospective Analysis,Blood,RT-PCR confirmed,median: 10.17±6.134,-,Positive rate in blood = 87.5% (7/8) in ICU and 66.7% (16/24) in non-ICU,"patients: 32, severity: non-ICU",04/13/2020
3,2020-03-03,Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore,https://doi.org/10.1001/jama.2020.3204,JAMA,Descriptive case series,Blood,RT-PCR confirmed,-,-,Only 8% blood samples positive,patients: 12,04/08/2020
4,2020-02-04,Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes,https://www.tandfonline.com/doi/full/10.1080/22221751.2020.1729071,Emerging Microbes & Infections,Retrospective Analysis,Blood,qRT-PCR confirmed,-,-,40% (6/15) of blood samples were positive; none of the patients with viremia blood had positive oral swabs,patients: 15,04/15/2020
